Clinical Microbiology and Infection
Volume 23, Issue 8, 2017

Response to Letter to the Editor by M. van der Werf, V. Hollo and C. Ködmön concerning ‘Multidrug-resistant tuberculosis and migration to Europe’ (Letter) (Open Access)

Hargreaves S. , Nellums L.B. , Nathavitharana R.R. , Friedland J.S.* , Lönnroth K. , Olaru I.D.
  • a Infectious Diseases & Immunity, Imperial College London, United Kingdom
  • b Infectious Diseases & Immunity, Imperial College London, United Kingdom
  • c Infectious Diseases & Immunity, Imperial College London, United Kingdom
  • d Infectious Diseases & Immunity, Imperial College London, United Kingdom
  • e Karolinska Institutet, Stockholm, Sweden; Global TB Programme, WHO, Geneva, Switzerland, Danish Research Centre for Migration Ethnicity and Health, University of Copenhagen, Denmark
  • f Division of Clinical Infectious Diseases, Research Centre, Borstel, Germany

Abstract

[No abstract available]

Author Keywords

[No Keywords available]

Index Keywords

Antitubercular Agents human multidrug resistant tuberculosis priority journal Mycobacterium tuberculosis Tuberculosis, Multidrug-Resistant resource allocation tuberculostatic agent Incidence Europe Letter human rights infection control prophylaxis Humans migration health care quality
Link
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017387231&doi=10.1016%2fj.cmi.2017.02.022&partnerID=40&md5=44818ec92b40fdcc69531294bbfaba7f
DOI: 10.1016/j.cmi.2017.02.022
ISSN: 1198743X
Original Language: English